Finish Your Race

Fort Worth, Texas resident and cancer survivor Don Armstrong is celebrating his fifth year in remission from Acute Myeloid Leukemia (AML). Don recently launched the Finish Your Race campaign where he will travel the world to run 10 marathons and raise $500,000 to benefit The Leukemia & Lymphoma Society.

In a year of thanks and celebration, one man – Don Armstrong, a courageous leukemia survivor – celebrates his fifth year in remission by running 10 marathons and raising $500,000 to benefit the Leukemia and Lymphoma Society with a mission to help find a cure for blood cancers. Armstrong is running not only to celebrate his survival and raise money for the cause, but also runs for those who cannot finish their race.

You can help in these ways:
 Make a donation
 Ask a business to sponsor him
 Offer in-kind support
 Join Team In Training
 The possibilities are endless. Send your ideas to info@finishyourrace.com

Armstrong will be running as a member of Team In Training in these cities:
 February 27th - Cowtown Half Marathon Fort Worth, Texas
 March 21st - Atlanta Half Marathon Atlanta, Georgia
 April 11th - Paris Marathon Paris, France
 May 1st – Capital City Half Marathon Columbus, Ohio
 June 6th - San Diego Rock n Roll Marathon San Diego, California
 June 27th - Seattle Rock n Roll Half Marathon Seattle, Washington
 August 1st - Chicago Rock n Roll Half Marathon Chicago, Illinois
 October 17th - Nike Marathon San Francisco, California
 November 7th - New York City Marathon New York City, New York
 December 12th - White Rock Half Marathon Dallas, Texas

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap